Phase II randomized, double-blind, placebo-controlled study of AMG 386 (trebananib) in combination with cisplatin and capecitabine in patients with metastatic gastro-oesophageal cancer (Q43471758)
Jump to navigation
Jump to search
scientific article published on 28 October 2012
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Phase II randomized, double-blind, placebo-controlled study of AMG 386 (trebananib) in combination with cisplatin and capecitabine in patients with metastatic gastro-oesophageal cancer |
scientific article published on 28 October 2012 |
Statements
1 reference
Phase II randomized, double-blind, placebo-controlled study of AMG 386 (trebananib) in combination with cisplatin and capecitabine in patients with metastatic gastro-oesophageal cancer (English)
1 reference
M M Eatock
1 reference
N C Tebbutt
1 reference
C L Bampton
1 reference
A H Strickland
1 reference
M Valladares-Ayerbes
1 reference
A Swieboda-Sadlej
1 reference
E Van Cutsem
1 reference
N Nanayakkara
1 reference
Y-N Sun
1 reference
Z D Zhong
1 reference
M B Bass
1 reference
A H Adewoye
1 reference
G Bodoky
1 reference
28 October 2012
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
Identifiers
1 reference